A study suggests that a new treatment called repetitive transcranial magnetic stimulation (rTMS) may lessen the non-pain symptoms of fibromyalgia, such as emotional and social disorders, and improve quality of life. The research is published in the March 26, 2014, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Fibromyalgia is a disease known for the main symptom of pain, however, it may also cause tiredness, interrupted sleep, depression, dizziness, digestive problems, headache, tingling, numbness and frequent urination.
“About five million Americans experience fibromyalgia, which affects women more often than men,” said study author Eric Guedj, MD, PhD, with Aix-Marseille University and National Center for Scientific Research in Marseille, France. “rTMS is a way to alter the excitability of the brain targeted by the device. A treatment such as this may provide a safe and noninvasive complement to pain pills in some people.”
For the study, 38 people who had persistent fibromyalgia pain for more than six months were randomly assigned to receive either rTMS or sham stimulation for 14 sessions over 10 weeks. For the sham stimulation, the electromagnetic coil looked and sounded like the actual treatment, but no stimulation was given. The researchers then assessed the changes in quality of life at the eleventh week, measured by a questionnaire, as well as brain metabolic changes using PET neuroimaging.
The study found that at week 11, people who received the rTMS therapy had greater improvement in quality of life and in mental components of the questionnaire than those in the sham stimulation group.
The improvement in quality of life involved mainly affective (mood or feelings), emotional (joy, sadness, anger, anxiety), and social areas (work performance, participation in social activities, contact with friends and engaging in hobbies and interests), and was correlated with brain PET metabolic changes.
At the beginning of the study, those receiving the treatment had an average score of 60 on the quality of life questionnaire, where scores range from zero to 100 and lower scores indicate better quality of life. Those receiving the sham treatment had an average score of 64.
After 11 weeks, the average score of those receiving the treatment had dropped by about 10 points, while the average score had increased by two points for those receiving the sham treatment.
The study was supported by Marseille Public Hospitals (APHM) and the French National Institute of Health and Medical Research (INSERM).
To learn more about fibromyalgia, please visit www.aan.com/patients.
The American Academy of Neurology, an association of more than 27,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson’s disease and epilepsy.
Rachel L. Seroka | American Academy of Neurology
The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung
A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences